HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ingramon

synthetic anti-inflammatory peptide, a fragment of C-terminal sequence (65-76) of monocytic chemotaxic protein-1

Also Known As:

anti-inflammatory peptide X

Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Peptide Fragments: 373
    - ingramon: 4

Experts

1.	Krasnikova, T L: 4 articles (02/2016 - 05/2009)
2.	Sidorova, M V: 4 articles (02/2016 - 05/2009)
3.	Bespalova, Zh D: 3 articles (10/2011 - 05/2009)
4.	Kukhtina, N B: 3 articles (10/2011 - 05/2009)
5.	Arefieva, T I: 2 articles (02/2016 - 10/2011)
6.	Noeva, E A: 2 articles (10/2011 - 01/2010)
7.	Potekhina, A V: 2 articles (10/2011 - 01/2010)
8.	Provatorov, S I: 2 articles (10/2011 - 01/2010)
9.	Aref'eva, T I: 2 articles (01/2010 - 05/2009)
10.	Pylaeva, E A: 1 article (02/2016)

Related Diseases

1.	Stable Angina 01/01/2010 - "The investigation enrolled 64 patients with stable angina who had undergone coronary bypass surgery, of them 34 patients received ingramon in addition to standard therapy. " 01/01/2010 - "To study the effect of the anti-inflammatory peptide preparation ingramon on the peripheral blood levels of inflammatory markers in patients with exercise-induced stable angina after coronary stenting (CS). "
2.	Acute Coronary Syndrome 05/01/2009 - "The clinical trials of Ingramon in patients with acute coronary syndromes and percutaneous coronary interventions, have been launched."
3.	Inflammation (Inflammations) 05/01/2009 - "Ingramon was accumulated in sites of inflammation in rats, and impaired monocyte and granulocyte accumulation occurred in different models of inflammation in rodents and primates. " 10/01/2011 - "The peptide from C-terminal domain of MCP-1 (Ingramon) has been shown to inhibit monocyte migration and possess anti-inflammatory activity in animal models of inflammation and post-angioplasty restenosis. "
4.	Glioma (Gliomas) 02/01/2016 - "Ingramon inhibited the effect of glioma-conditioned medium on monocyte migration." 02/01/2016 - "Ingramon, a Peptide Inhibitor of MCP-1 Chemokine, Reduces Migration of Blood Monocytes Stimulated by Glioma-Conditioned Medium."
5.	Coronary Disease (Coronary Heart Disease) 01/01/2010 - "When added to standard therapy, ingramon exerts a positive effect against risk factors for coronary heart disease (CHD) and its events. "

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Chemokines
3.	Conditioned Culture Media

Related Therapies and Procedures

1.	Percutaneous Coronary Intervention
2.	Therapeutics